BDC Venture Capital Seeds viDA Therapeutics
Vancouver-based viDA Therapeutics Inc., a company focused on development and commercialization of novel and targeted therapeutics for the treatment of inflammatory and age related diseases, has obtained additional seed-stage funding totaling $750,000 from BDC Venture Capital. The new tranche brings the company's total venture capital financing to date to $3.7 million. Proceeds of the investment will allow viDA to enter the next phases of its research and development.
24 April 2013•3 mins read
